| Arlene Maire Samen, APRN | |
|
723 E 12200 S Ste 100, Draper, UT 84020-9885 | |
| (801) 369-8989 | |
| Not Available |
| Full Name | Arlene Maire Samen |
|---|---|
| Gender | Female |
| Speciality | Clinical Nurse Specialist - Psychiatric/mental Health |
| Location | 723 E 12200 S Ste 100, Draper, Utah |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1437864683 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 364SP0808X | Clinical Nurse Specialist - Psychiatric/mental Health | 103560-4405 (Utah) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Arlene Maire Samen, APRN 723 E 12200 S Ste 100, Draper, UT 84020-9885 Ph: () - | Arlene Maire Samen, APRN 723 E 12200 S Ste 100, Draper, UT 84020-9885 Ph: (801) 369-8989 |
News Archive
A survey of Geisinger employees conducted over two weeks in December 2020 found a steady increase in intent among healthcare workers to receive the COVID-19 vaccine.
Ohr Pharmaceutical today announced the initiation of a Phase II clinical trial to evaluate the efficacy and safety of Squalamine Eye Drops for the treatment of the wet form of age-related macular degeneration.
Among women with early stage breast cancer, genetic variation of a certain enzyme appears to be associated with clinical outcomes for women treated with tamoxifen, according to a study in the October 7 issue of JAMA.
Rural hospitals are more likely than urban facilities to have access to telehealth, a once-underused service that now is playing a key role in treating coronavirus patients, according to research by two health administration professors in Florida Atlantic University's College of Business.
An Artificial Intelligence (AI) algorithm has been trained to pick up early signs of cognitive decline, which could result in Alzheimer's disease (AD).
› Verified 6 days ago